Supernus Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
15 Nov 23 | SellUS$46,626 | Frederick Hudson | Individual | 1,636 | US$28.50 | |
25 Aug 23 | SellUS$162,215 | Tami Martin | Individual | 5,135 | US$31.59 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 20,542 | 0.0335% |
State or Government | 25,027 | 0.0408% |
Individual Insiders | 2,333,217 | 3.8% |
Hedge Funds | 4,650,000 | 7.58% |
Institutions | 54,331,039 | 88.5% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
10,382,770 | US$313.9m | 1.99% | 0.01% | |||
6,214,731 | US$187.9m | 2.35% | no data | |||
4,650,000 | US$140.6m | -8.68% | 3.67% | |||
2,737,716 | US$82.8m | -0.48% | 0.09% | |||
2,456,369 | US$74.3m | 6.12% | 0.01% | |||
2,062,326 | US$62.3m | 7.58% | no data | |||
1,939,365 | US$58.6m | 17.2% | 0.25% | |||
1,937,667 | US$58.6m | 0.95% | no data | |||
1,904,864 | US$57.6m | 11.7% | 0.8% | |||
1,636,490 | US$49.5m | -5.42% | 0.07% | |||
1,378,422 | US$41.7m | -4.17% | 0.06% | |||
1,317,526 | US$39.8m | -6.3% | 0.35% | |||
1,245,154 | US$37.6m | 13.9% | no data | |||
1,159,828 | US$35.1m | -2.37% | 1.07% | |||
1,046,082 | US$31.6m | 13.6% | 0.02% | |||
1,032,141 | US$31.2m | 12.1% | 0.23% | |||
826,488 | US$25.0m | -9.85% | 3.45% | |||
690,398 | US$20.9m | -2.92% | 0.02% | |||
648,446 | US$19.6m | -11.7% | no data | |||
559,702 | US$16.9m | -1.64% | no data | |||
555,930 | US$16.8m | 0% | no data | |||
541,973 | US$16.4m | 0% | 0.01% | |||
516,773 | US$15.6m | -2.49% | 0.94% | |||
491,718 | US$14.9m | -23.4% | 0.01% | |||
473,304 | US$14.3m | 64.9% | no data |